Document Detail


Lactosucrose inhibits body fat accumulation in rats by decreasing intestinal lipid absorption.
MedLine Citation:
PMID:  19270366     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Lactosucrose (LS, 4(G)-beta-D-galactosylsucrose) is a non-digestible oligosaccharide, and the consumption of LS selectively increases the proportion of intestinal bifidobacteria. We examined in this study the hypolipidemic potential of LS. An oral triolein tolerance test on rats indicated that LS reduced the elevation of serum triglyceride (TG) and free fatty acids (FFA). Furthermore, LS inhibited the enzymatic digestion of triolein by pancreatic lipase in vitro. NMR spectroscopy showed that LS formed an intermolecular complex with triolein. The long-term consumption of a diet containing 5% LS for 8 weeks significantly decreased the weight of abdominal adipose tissue when compared with that of the control group. Thus, LS may reduce adipose tissue accumulation by inhibiting intestinal lipid absorption via a direct interaction with TG.
Authors:
Akiko Mizote; Yoshifumi Taniguchi; Yasuhiko Takei; Satomi Koya-Miyata; Keizo Kohno; Kanso Iwaki; Mayumi Kurose; Kazuyuki Oku; Hiroto Chaen; Shigeharu Fukuda
Related Documents :
2539446 - Specific effects of fermentable carbohydrates on blood urea flux and ammonia absorption...
8174956 - Comparison of different lipid substrates on intestinal adaptation in the rat.
20556376 - Intestinal microbiota diversity of the flat fish solea senegalensis (kaup, 1858) follow...
11591236 - Increasing viscosity of the intestinal contents alters small intestinal structure and i...
10735206 - Model of physiological stress in chickens 4. digestion and metabolism.
15254886 - Insulin-nonspecific reduction in skeletal muscle glucose transport in high-fat-fed rats.
Publication Detail:
Type:  Journal Article     Date:  2009-03-07
Journal Detail:
Title:  Bioscience, biotechnology, and biochemistry     Volume:  73     ISSN:  1347-6947     ISO Abbreviation:  Biosci. Biotechnol. Biochem.     Publication Date:  2009 Mar 
Date Detail:
Created Date:  2009-03-23     Completed Date:  2009-06-08     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9205717     Medline TA:  Biosci Biotechnol Biochem     Country:  Japan    
Other Details:
Languages:  eng     Pagination:  582-7     Citation Subset:  IM    
Affiliation:
Biomedical Institute, Research Center, Hayashibara Biochemical Laboratories, Inc., Okayama, Japan. fujisaki@hayashibara.co.jp
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Abdominal Fat / drug effects,  metabolism
Adipose Tissue / drug effects*,  metabolism*
Animals
Dietary Supplements
Fatty Acids, Nonesterified / blood
Intestinal Absorption / drug effects*
Lipase / metabolism
Lipid Metabolism / drug effects*
Male
Obesity / prevention & control
Pancreas / enzymology
Rats
Rats, Wistar
Time Factors
Triglycerides / blood
Triolein / metabolism
Trisaccharides / metabolism,  pharmacology*
Veins / drug effects,  metabolism
Chemical
Reg. No./Substance:
0/Fatty Acids, Nonesterified; 0/Triglycerides; 0/Trisaccharides; 122-32-7/Triolein; 87419-56-5/galactosucrose; EC 3.1.1.3/Lipase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Overexpression of CHMP6 induces cellular oncosis and apoptosis in HeLa cells.
Next Document:  Dietary cycloinulooligosaccharides enhance intestinal immunoglobulin A production in mice.